BGB-002

N/A

Report date: 2023/05/22 10:17:12
NME

Base Information

Drug NameBGB-002
Drug Alias NameBGB-002
ClassificationSmall molecules
Mechanisms of ActionAXL receptor tyrosine kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBergenbio
China Registration ClassN/A

Develop Information

Active CompaniesBergenbio
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A